Skip to main content

Tribenzor

NDC 0713-0876 · Cosette Pharmaceuticals, Inc.

Generic nameolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE
Strength5; 25; 40 mg/1; mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryNDA

Packages

0713-0876-30 — 30 TABLET, FILM COATED in 1 BOTTLE (0713-0876-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0713-0862 — olmesartan medoxomil, 0713-0863 — olmesartan medoxomil-hydrochlorothiazide, 0713-0864 — olmesartan medoxomil-hydrochlorothiazide, 0713-0865 — olmesartan medoxomil-hydrochlorothiazide, 0713-0870 — amlodipine besylate and olmesartan medoxomil, 0713-0871 — amlodipine besylate and olmesartan medoxomil, 0713-0872 — amlodipine besylate and olmesartan medoxomil, 0713-0873 — amlodipine besylate and olmesartan medoxomil, 0713-0874 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 0713-0875 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 0713-0877 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 0713-0878 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 0713-0940 — olmesartan medoxomil, 0713-0941 — olmesartan medoxomil, 0713-0942 — olmesartan medoxomil, 0713-0943 — olmesartan medoxomil-hydrochlorothiazide, 0713-0944 — olmesartan medoxomil-hydrochlorothiazide, 0713-0945 — olmesartan medoxomil-hydrochlorothiazide, 0781-2074 — Triamterene and Hydrochlorothiazide, 0904-6369 — Amlodipine Besylate, +1450 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels